INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 42h ago
House PTR2h ago
SEC 13F2h ago
Robinhood Chain2h ago

Results

21,218 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
19
FK
Feeley KevinCHIEF FINANCIAL OFFICER
WGSGeneDx Holdings Corp.
Open-market sale
SELL$4,961
52 sh
Sep 16, 2026Sep 18, 2026
Page 122 of 531
← PrevNext →
traded Sep 16, 2026
+2d
SEC Form 4

Evidence

19
OO
Okupe OluyemiChief Financial Officer
HIMSHims & Hers Health, Inc.
Open-market sale · 10b5-1 plan
SELL$355K
12.3K sh
Sep 17, 2026Sep 18, 2026
traded Sep 17, 2026
+1dSEC Form 4

Evidence

18
LF
Lo FrancisChief People Officer
ADPTAdaptive Biotechnologies Corp
Open-market sale · 10b5-1 plan
SELL$3.01M
107.5K sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

17
FR
Furner John R.Director, President & CEO
WMTWalmart Inc.
Open-market sale · 10b5-1 plan
SELL$646K
6,045 sh
Sep 17, 2026Sep 18, 2026
traded Sep 17, 2026
+1dSEC Form 4

Evidence

17
FR
Furner John R.Director, President & CEO
WMTWalmart Inc.
Open-market sale · 10b5-1 plan
SELL$754K
7,080 sh
Sep 17, 2026Sep 18, 2026
traded Sep 17, 2026
+1dSEC Form 4

Evidence

16
PA
Polovin AndrewEVP, Chief Legal Officer
TEMTempus AI, Inc.
Open-market sale · 10b5-1 plan
SELL$221K
2,951 sh
Sep 17, 2026Sep 18, 2026
traded Sep 17, 2026
+1dSEC Form 4

Evidence

16
LL
Lin LaurenCLO, CCO and Secretary
WLTHWEALTHFRONT CORP
Open-market sale · 10b5-1 plan
SELL$46K
4,574 sh
Sep 17, 2026Sep 18, 2026
traded Sep 17, 2026
+1dSEC Form 4

Evidence

16
WL
Wang LingkeDirector, President
LIFEEthos Technologies Inc.
Open-market sale · 10b5-1 plan
SELL$4.31M
110.6K sh
Sep 17, 2026Sep 18, 2026
traded Sep 17, 2026
+1dSEC Form 4

Evidence

16
MA
Mancini AnthonySee Remarks
RVMDRevolution Medicines, Inc.
Open-market sale · 10b5-1 plan
SELL$5,266
27 sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

14
SB
Sousa Mauad BrunoDirector
AUGOAura Minerals Inc.
Open-market sale
SELL$853
29 sh
Sep 17, 2026Sep 18, 2026
traded Sep 17, 2026
+1dSEC Form 4

Evidence

14
SB
Sousa Mauad BrunoDirector
AUGOAura Minerals Inc.
Open-market sale
SELL$19K
606 sh
Sep 17, 2026Sep 18, 2026
traded Sep 17, 2026
+1dSEC Form 4

Evidence

14
SB
Sousa Mauad BrunoDirector
AUGOAura Minerals Inc.
Open-market sale
SELL$19K
200 sh
Sep 17, 2026Sep 18, 2026
traded Sep 17, 2026
+1dSEC Form 4

Evidence

13
RL
Reynoso Jamie L.CEO, Medicare Advantage
CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
Open-market sale · 10b5-1 plan
SELL$8,760
1,921 sh
Sep 17, 2026Sep 18, 2026
traded Sep 17, 2026
+1dSEC Form 4

Evidence

13
FR
Fukushima RyanCEO, Data
TEMTempus AI, Inc.
Open-market sale · 10b5-1 plan
SELL$49K
700 sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

12
ZR
Zage George Raymond IIIDirector, 10% Owner
GRNDGrindr Inc.
Open-market sale · 10b5-1 plan
SELL$2.56M
166.4K sh
Sep 17, 2026Sep 18, 2026
traded Sep 17, 2026
+1dSEC Form 4

Evidence

11
NJ
Nicholas Christopher JamesExecutive Vice President
WMTWalmart Inc.
Open-market sale · 10b5-1 plan
SELL$149K
1,395 sh
Sep 17, 2026Sep 18, 2026
traded Sep 17, 2026
+1dSEC Form 4

Evidence

11
Sahin UgurChief Executive Officer, 10% Owner
BNTXBioNTech SE
Open-market sale · 10b5-1 plan
SELL$3.35M
34.0K sh
Sep 17, 2026Sep 18, 2026
traded Sep 17, 2026
+1dSEC Form 4

Evidence

11
NJ
Nicholas Christopher JamesExecutive Vice President
WMTWalmart Inc.
Open-market sale · 10b5-1 plan
SELL$160K
1,505 sh
Sep 17, 2026Sep 18, 2026
traded Sep 17, 2026
+1dSEC Form 4

Evidence

11
Sahin UgurChief Executive Officer, 10% Owner
BNTXBioNTech SE
Open-market sale · 10b5-1 plan
SELL$2.89M
30.0K sh
Sep 18, 2026Sep 18, 2026
traded Sep 18, 2026
+0dSEC Form 4

Evidence

10
CM
Cummings MarthaDirector
MQMarqeta, Inc.
Open-market sale · 10b5-1 plan
SELL$11K
713 sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

9
CG
Colis Peter GeorgeDirector, CEO and Secretary
LIFEEthos Technologies Inc.
Open-market sale · 10b5-1 plan
SELL$822K
21.1K sh
Sep 17, 2026Sep 18, 2026
traded Sep 17, 2026
+1dSEC Form 4

Evidence

9
WL
Wang LingkeDirector, President
LIFEEthos Technologies Inc.
Open-market sale · 10b5-1 plan
SELL$285K
7,431 sh
Sep 17, 2026Sep 18, 2026
traded Sep 17, 2026
+1dSEC Form 4

Evidence

9
CG
Colis Peter GeorgeDirector, CEO and Secretary
LIFEEthos Technologies Inc.
Open-market sale · 10b5-1 plan
SELL$357K
9,648 sh
Sep 18, 2026Sep 18, 2026
traded Sep 18, 2026
+0dSEC Form 4

Evidence

9
SR
Sullivan Christopher RyanChief Financial Officer
AVTXAvalo Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$202K
12.4K sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

9
CG
Colis Peter GeorgeDirector, CEO and Secretary
LIFEEthos Technologies Inc.
Open-market sale · 10b5-1 plan
SELL$259K
7,190 sh
Sep 18, 2026Sep 18, 2026
traded Sep 18, 2026
+0dSEC Form 4

Evidence

9
CG
Colis Peter GeorgeDirector, CEO and Secretary
LIFEEthos Technologies Inc.
Open-market sale · 10b5-1 plan
SELL$850K
21.4K sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

7
EM
Eisen Anthony MathewDirector
XYZBlock, Inc.
Open-market sale · 10b5-1 plan
SELL$468K
6,000 sh
Sep 17, 2026Sep 18, 2026
traded Sep 17, 2026
+1dSEC Form 4

Evidence

7
EM
Eisen Anthony MathewDirector
XYZBlock, Inc.
Open-market sale · 10b5-1 plan
SELL$459K
6,000 sh
Sep 18, 2026Sep 18, 2026
traded Sep 18, 2026
+0dSEC Form 4

Evidence

7
EM
Eisen Anthony MathewDirector
XYZBlock, Inc.
Open-market sale · 10b5-1 plan
SELL$470K
6,000 sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

6
CG
Colis Peter GeorgeDirector, CEO and Secretary
LIFEEthos Technologies Inc.
Open-market sale · 10b5-1 plan
SELL$244K
6,495 sh
Sep 18, 2026Sep 18, 2026
traded Sep 18, 2026
+0dSEC Form 4

Evidence

6
CG
Colis Peter GeorgeDirector, CEO and Secretary
LIFEEthos Technologies Inc.
Open-market sale · 10b5-1 plan
SELL$72K
1,900 sh
Sep 17, 2026Sep 18, 2026
traded Sep 17, 2026
+1dSEC Form 4

Evidence

6
CG
Colis Peter GeorgeDirector, CEO and Secretary
LIFEEthos Technologies Inc.
Open-market sale · 10b5-1 plan
SELL$80K
1,971 sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

5
HK
Hanson KristopherGeneral Counsel
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$193K
16.5K sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

4
LF
Lo FrancisChief People Officer
ADPTAdaptive Biotechnologies Corp
Open-market sale · 10b5-1 plan
SELL$225K
7,869 sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

4
OO
Offer OrChief Executive Officer
SMWBSIMILARWEB LTD.
Open-market sale · 10b5-1 plan
SELL$384K
45.7K sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

4
OO
Offer OrChief Executive Officer
SMWBSIMILARWEB LTD.
Open-market sale · 10b5-1 plan
SELL$254K
30.4K sh
Sep 17, 2026Sep 18, 2026
traded Sep 17, 2026
+1dSEC Form 4

Evidence

3
CG
Colis Peter GeorgeDirector, CEO and Secretary
LIFEEthos Technologies Inc.
Open-market sale · 10b5-1 plan
SELL$12K
315 sh
Sep 17, 2026Sep 18, 2026
traded Sep 17, 2026
+1dSEC Form 4

Evidence

3
SE
Song EstherSee Remarks
SYNASYNAPTICS Inc
Open-market sale · 10b5-1 plan
SELL$5,836
63 sh
Sep 18, 2026Sep 18, 2026
traded Sep 18, 2026
+0dSEC Form 4

Evidence

3
WL
Wang LingkeDirector, President
LIFEEthos Technologies Inc.
Open-market sale · 10b5-1 plan
SELL$12K
315 sh
Sep 17, 2026Sep 18, 2026
traded Sep 17, 2026
+1dSEC Form 4

Evidence

3
AL
Azar Samak LChief Legal Officer
GFSGLOBALFOUNDRIES Inc.
Open-market sale · 10b5-1 plan
SELL$15K
335 sh
Sep 17, 2026Sep 18, 2026
traded Sep 17, 2026
+1dSEC Form 4

Evidence